Prophylaxis of Infective Endocarditis: A Cross Sectional Survey among Physician Members of the Portuguese Society of Cardiology

Catarina de Sousa; Ana G. Almeida; Fausto J. Pinto

doi:10.20344/amp.17379

Autores

Catarina de Sousa Centro Cardiovascular da Universidade de Lisboa. Faculdade de Medicina. Universidade de Lisboa. Lisboa. Lusíadas Knowledge Center – Lusíadas Saúde. Lisboa. https://orcid.org/0000-0003-1709-6283
Ana G. Almeida Centro Cardiovascular da Universidade de Lisboa. Faculdade de Medicina. Universidade de Lisboa. Lisboa. Departamento de Coração e Vasos. Hospital de Santa Maria. Centro Hospitalar Universitário Lisboa Norte. Lisboa. https://orcid.org/0000-0003-0360-4363
Fausto J. Pinto Centro Cardiovascular da Universidade de Lisboa. Faculdade de Medicina. Universidade de Lisboa. Lisboa. Departamento de Coração e Vasos. Hospital de Santa Maria. Centro Hospitalar Universitário Lisboa Norte. Lisboa. https://orcid.org/0000-0002-8034-4529

DOI:

https://doi.org/10.20344/amp.17379

Palavras-chave:

Endocardite, Inquéritos e Questionários, Portugal, Profilaxia Antibiótica

Resumo

Introdução: Na última década, a restrição das indicações para a profilaxia antibiótica na endocardite infeciosa teve um impacto incerto na incidência desta condição. Uma vez que não existem dados sobre a prática da profilaxia da endocardite infeciosa em Portugal, procurámos caracterizar o padrão de utilização antibiótica para a profilaxia da endocardite infeciosa e a conformidade/sensibilização das orientações científicas entre médicos, membros da Sociedade Portuguesa de Cardiologia.
Material e Métodos: Foi realizado um estudo observacional transversal. Um questionário online de autopreenchimento com 12 itens sobre profilaxia da endocardite infeciosa foi enviado a 1330 médicos, especialistas e internos, sócios da Sociedade Portuguesa de Cardiologia. Foi realizada uma análise estatística descritiva.
Resultados: Foram validados 253 questionários respondidos. Oitenta e sete por cento dos inquiridos eram cardiologistas (especialistas ou internos), a maioria entre os 30 e os 40 anos (26,7%) e os 50 e 80 anos (44,3%). A maior parte (83,0%) segue as orientações científicas europeias. Ainda assim, 61,0% admitiu ter ou poder ter dúvidas sobre a profilaxia da endocardite infeciosa em determinados doentes. Verificou-se uma adesão variável às orientações científicas. A necessidade de mais evidência científica foi defendida por 60,6% dos respondedores.
Conclusão: Entre médicos da Sociedade Portuguesa de Cardiologia, a profilaxia da endocardite infeciosa foi geralmente orientada pelas orientações científicas europeias. Existiu, no entanto, uma evidente discrepância entre as orientações e a perceção do risco de endocardite infeciosa na prática clínica. Isto reforça a necessidade de acesso a dados científicos mais robustos.

Downloads

Não há dados estatísticos.

Referências

Cahill TJ, Baddour LM, Habib G, Hoen B, Salaun E, Pettersson GB, et al. Challenges in infective endocarditis. J Am Coll Cardiol. 2017;69:325–44. DOI: https://doi.org/10.1016/j.jacc.2016.10.066

Bin Abdulhak AA, Baddour LM, Erwin PJ, Hoen B, Chu VH, Mensah GA, et al. Global and regional burden of infective endocarditis, 1990-2010: a systematic review of the literature. Glob Heart 2014;9:131–43. DOI: https://doi.org/10.1016/j.gheart.2014.01.002

Murdoch DR, Corey GR, Hoen B, Miro J, Fowler V, Bayer A, et al. Clinical presentation, etiology and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis-prospective cohort study. Ann Intern Med. 2009;169:463–73. DOI: https://doi.org/10.1001/archinternmed.2008.603

Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, et al. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019;40:3222–32. DOI: https://doi.org/10.1093/eurheartj/ehz620

Lewis T, Grant R. Observations relating to subacute infective endocarditis. Heart. 1923;10:21-77.

Elliott SD. Bacteriæmia and oral sepsis. Proc R Soc Med. 1939;32:747–54. DOI: https://doi.org/10.1177/003591573903200712

Hilson GR. Is chemoprophylaxis necessary? Proc Roy Soc Med. 1970;63:267–71. DOI: https://doi.org/10.1177/003591577006300321

Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC guidelines for the management of infective endocarditis. Eur Heart J. 2015;36:3075–128. DOI: https://doi.org/10.1093/eurheartj/ehv319

Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association. Circulation. 2007;116:1736-54. DOI: https://doi.org/10.1161/CIRCULATIONAHA.106.183095

Dayer MJ, Chambers JB, Prendergast B, Sandoe JA, Thornhill MH. NICE guidance on antibiotic prophylaxis to prevent infective endocarditis: a survey of clinicians’ attitudes. QJM. 2013;106:237–43. DOI: https://doi.org/10.1093/qjmed/hcs235

Tarasoutchi F, Montera M, Grinberg M, Barbosa M, Piñeiro D, Sánchez C, et al. Diretriz brasileira de valvopatias - SBC 2011/ I Diretriz interamericana de valvopatias - SIAC 2011. Arq Bras Cardiol. 2011;97:1-67. DOI: https://doi.org/10.1590/S0066-782X2011002000001

Torres F, Renilla A, Florez J, Secades S, Benito E, de la Hera J. Knowledge of infective endocarditis and prophylaxis among Spanish dentists. Rev Esp Cardiol. 2012;65:1134–5. DOI: https://doi.org/10.1016/j.rec.2012.04.007

Cloitre A, Duval X, Hoen B, Alla F. A nationwide survey of French dentists’ knowledge and implementation of current guidelines for antibiotic prophylaxis of infective endocarditis in patients with. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125:295–303. DOI: https://doi.org/10.1016/j.oooo.2017.10.002

Khan O, Shafi AM, Timmis A. International guideline changes and the incidence of infective endocarditis: a systematic review. Open Heart. 2016;3:e000498. DOI: https://doi.org/10.1136/openhrt-2016-000498

Keller K, Bardeleben RS Von, Ostad MA, Hobohm L, Munzel T, Konstantinides S, et al. Temporal trends in the prevalence of infective endocarditis in Germany between 2005 and 2014. Am J Cardiol. 2017;119:317–22. DOI: https://doi.org/10.1016/j.amjcard.2016.09.035

Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB, Thornhill MH. Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis. Lancet. 2015;385:1219–28.

Sousa C, Nogueira P, Pinto FJ. Insight into the epidemiology of infective endocarditis in Portugal: a contemporary nationwide study from 2010 to 2018. BMC Cardiovasc Disord. 2021;21:138. DOI: https://doi.org/10.1186/s12872-021-01937-3

de Sousa C, Ribeiro RM, Pinto FJ. The burden of infective endocarditis in Portugal in the last 30 years – a systematic review of observational studies. Rev Port Cardiol. 2021;40:205–17. DOI: https://doi.org/10.1016/j.repc.2020.07.014

Abdulaziz K, Brehaut J, Taljaard M, Émond M, Sirois MJ, Lee JS, et al. National survey of physicians to determine the effect of unconditional incentives on response rates of physician postal surveys. BMJ Open. 2015;5:1–6. DOI: https://doi.org/10.1136/bmjopen-2014-007166

Baddour LM, Wilson WR, Bayer AS, Fowler VG, Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132:1435–86. DOI: https://doi.org/10.1161/CIR.0000000000000296

Metcalfe D, Pitkeathley C, Herring J. ‘Advice, not orders’? The evolving legal status of clinical guidelines. J Med Ethics. 2020;medethics-2020-106592. doi: 10.1136/medethics-2020-106592. DOI: https://doi.org/10.1136/medethics-2020-106592

National Institute for Health and Care Excellence. Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures. 2008. [cited 2019 May 16]. Available from: https://www.nice.org.uk/guidance/cg64.

Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): The Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2009;30:2369–413. DOI: https://doi.org/10.1093/eurheartj/ehp285

Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB, Thornhill MH. An increase in the incidence of infective endocarditis in England since 2008: a secular trend interrupted time series analysis. Lancet. 2015;385:1219–28. DOI: https://doi.org/10.1016/S0140-6736(14)62007-9

Van Den Brink FS, Swaans MJ, Hoogendijk MG, Alipour A, Kelder JC, Jaarsma W, et al. Increased incidence of infective endocarditis after the 2009 European Society of Cardiology guideline update: a nationwide study in the Netherlands. Eur Hear J Qual Care Clin Outcomes. 2017;3:141–7. DOI: https://doi.org/10.1093/ehjqcco/qcw039

Cahill TJ, Harrison JL, Jewell P, Onakpoya I, Chambers JB, Dayer M, et al. Antibiotic prophylaxis for infective endocarditis: a systematic review and meta-analysis. Heart. 2017;103:937–44. DOI: https://doi.org/10.1136/heartjnl-2015-309102

Grattan MJ, Power A, Fruitman DS, Islam S, Mackie AS. The impact of infective endocarditis prophylaxis recommendations on the practices of pediatric and adult congenital cardiologists. J Cardiol. 2015;31:1497. e23-8. DOI: https://doi.org/10.1016/j.cjca.2015.04.032

Pharis CS, Conway J, Warren AE, Bullock A, MacKie AS. The impact of 2007 infective endocarditis prophylaxis guidelines on the practice of congenital heart disease specialists. Am Heart J. 2011;161:123–9. DOI: https://doi.org/10.1016/j.ahj.2010.09.024

Armstrong ML, DeBoer S, Cetta F. Infective endocarditis after body art: a review of the literature and concerns. J Adolesc Health. 2008;43:217–25. DOI: https://doi.org/10.1016/j.jadohealth.2008.02.008

Thornhill MH, Jones S, Prendergast B, Baddour LM, Chambers JB, Lockhart PB, et al. Quantifying infective endocarditis risk in patients with predisposing cardiac conditions. Eur Heart J. 2018;39:586–95. DOI: https://doi.org/10.1093/eurheartj/ehx655

Sun YP, O’Gara PT. Cardiovascular conditions predisposing to infective endocarditis: time to reconsider the current risk classification system? Eur Heart J. 2018;39:596–8. DOI: https://doi.org/10.1093/eurheartj/ehx797

Everett E, Hirschmann J. Transient bacteriemia and endocarditis prophylaxis. a review. Medicine. 1977;56:61–77. DOI: https://doi.org/10.1097/00005792-197756010-00004

Lockhart PB, Brennan MT, Sasser HC, Fox PC, Paster BJ, Bahrani-Mougeot FK. Bacteremia associated with toothbrushing and dental extraction. Circulation. 2008;117:3118–25. DOI: https://doi.org/10.1161/CIRCULATIONAHA.107.758524

Holland TL, Baddour LM, Bayer AS, Hoen B, Miro JM, Fowler VG. Infective endocarditis. Nat Rev Dis Prim. 2017;2:1–49. DOI: https://doi.org/10.1038/nrdp.2016.59

McFarlane E, Olmsted MG, Murphy J, Hill CA. Nonresponse bias in a mail survey of physicians. Eval Heal Prof. 2007;30:170–85. DOI: https://doi.org/10.1177/0163278707300632